239 related articles for article (PubMed ID: 8752294)
1. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.
Clark HF; Offit PA; Ellis RW; Eiden JJ; Krah D; Shaw AR; Pichichero M; Treanor JJ; Borian FE; Bell LM; Plotkin SA
J Infect Dis; 1996 Sep; 174 Suppl 1():S73-80. PubMed ID: 8752294
[TBL] [Abstract][Full Text] [Related]
2. WC3 reassortant vaccines in children.
Clark HF; Offit PA; Ellis RW; Krah D; Shaw AR; Eiden JJ; Pichichero M; Treanor JJ
Arch Virol Suppl; 1996; 12():187-98. PubMed ID: 9015115
[TBL] [Abstract][Full Text] [Related]
3. Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4.
Clark HF; Lawley D; Shrager D; Jean-Guillaume D; Offit PA; Whang SY; Eiden JJ; Bennett PS; Kaplan KM; Shaw AR
Pediatr Infect Dis J; 2004 Mar; 23(3):206-11. PubMed ID: 15014293
[TBL] [Abstract][Full Text] [Related]
4. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
[TBL] [Abstract][Full Text] [Related]
5. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq.
Matthijnssens J; Joelsson DB; Warakomski DJ; Zhou T; Mathis PK; van Maanen MH; Ranheim TS; Ciarlet M
Virology; 2010 Aug; 403(2):111-27. PubMed ID: 20451234
[TBL] [Abstract][Full Text] [Related]
6. Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3.
Clark HF; Borian FE; Plotkin SA
J Infect Dis; 1990 Jun; 161(6):1099-104. PubMed ID: 2161038
[TBL] [Abstract][Full Text] [Related]
7. Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus.
Ward RL; Knowlton DR; Greenberg HB; Schiff GM; Bernstein DI
J Virol; 1990 Jun; 64(6):2687-91. PubMed ID: 2159538
[TBL] [Abstract][Full Text] [Related]
8. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
[TBL] [Abstract][Full Text] [Related]
9. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.
Clark HF; Bernstein DI; Dennehy PH; Offit P; Pichichero M; Treanor J; Ward RL; Krah DL; Shaw A; Dallas MJ; Laura D; Eiden JJ; Ivanoff N; Kaplan KM; Heaton P
J Pediatr; 2004 Feb; 144(2):184-90. PubMed ID: 14760258
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants.
Treanor JJ; Clark HF; Pichichero M; Christy C; Gouvea V; Shrager D; Palazzo S; Offit P
Pediatr Infect Dis J; 1995 Apr; 14(4):301-7. PubMed ID: 7603812
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
Vesikari T; Matson DO; Dennehy P; Van Damme P; Santosham M; Rodriguez Z; Dallas MJ; Heyse JF; Goveia MG; Black SB; Shinefield HR; Christie CD; Ylitalo S; Itzler RF; Coia ML; Onorato MT; Adeyi BA; Marshall GS; Gothefors L; Campens D; Karvonen A; Watt JP; O'Brien KL; DiNubile MJ; Clark HF; Boslego JW; Offit PA; Heaton PM;
N Engl J Med; 2006 Jan; 354(1):23-33. PubMed ID: 16394299
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus vaccines: an overview.
Midthun K; Kapikian AZ
Clin Microbiol Rev; 1996 Jul; 9(3):423-34. PubMed ID: 8809469
[TBL] [Abstract][Full Text] [Related]
13. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
Clark HF; Offit PA; Plotkin SA; Heaton PM
Pediatr Infect Dis J; 2006 Jul; 25(7):577-83. PubMed ID: 16804425
[TBL] [Abstract][Full Text] [Related]
14. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
Ciarlet M; Schödel F
Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144
[TBL] [Abstract][Full Text] [Related]
15. Dual Recognition of Sialic Acid and αGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains.
Alfajaro MM; Kim JY; Barbé L; Cho EH; Park JG; Soliman M; Baek YB; Kang MI; Kim SH; Kim GJ; Park SI; Pendu JL; Cho KO
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243129
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
[TBL] [Abstract][Full Text] [Related]
17. Immune response of infants and children to low-passage bovine rotavirus (strain WC3).
Clark HF; Furukawa T; Bell LM; Offit PA; Perrella PA; Plotkin SA
Am J Dis Child; 1986 Apr; 140(4):350-6. PubMed ID: 3006476
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
Goveia MG; Rodriguez ZM; Dallas MJ; Itzler RF; Boslego JW; Heaton PM; DiNubile MJ;
Pediatr Infect Dis J; 2007 Dec; 26(12):1099-104. PubMed ID: 18043445
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants.
Bernstein DI; Smith VE; Sander DS; Pax KA; Schiff GM; Ward RL
J Infect Dis; 1990 Nov; 162(5):1055-62. PubMed ID: 2172394
[TBL] [Abstract][Full Text] [Related]
20. Bovine rotavirus pentavalent vaccine development in India.
Zade JK; Kulkarni PS; Desai SA; Sabale RN; Naik SP; Dhere RM
Vaccine; 2014 Aug; 32 Suppl 1():A124-8. PubMed ID: 25091665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
